Marth, Christian. “Olaparib Shows Significant Progression-Free Survival Benefit in Phase III SOLO2 Trial:  ”. Cancer Breaking News 5, no. 2 (August 17, 2017): 3–4. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/177.